Last update:
Oncology news
Single-cell maps show chemokine signals collapse as aggressive lymphoma spreads
Lymph nodes are key control centers in the immune system and play an important role in defending the body against infections and tumors. For these processes to function properly, immune cells (B cells and T cells) must be ...
19 minutes ago
0
0
Brain metastasis study reveals how tumors hijack immune cells
A team from the Spanish National Cancer Research Centre (CNIO) has discovered a novel way in which tumor cells alter the brain to establish themselves and spread cancer. They also demonstrate that a drug that prevents this ...
59 minutes ago
0
0
Common blood pressure drug can boost cancer treatment
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can significantly enhance the cancer-killing ...
2 hours ago
0
1
Simple blood tests may predict response to lymphoma treatment
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy ...
2 hours ago
0
2
Clinical trial finds hormone patches to be effective for locally advanced prostate cancer
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL (University College London) ...
1 hour ago
0
0
How inflammation may prime the gut for cancer
Chronic inflammation can raise a person's risk of cancer, and a new study reveals key details about how that might happen in the gut and points to better ways to identify and reduce risk. Scientists at the Broad Institute ...
6 hours ago
0
6
Immune response to cancer may cause autoimmune disorders, including anti-NMDA receptor encephalitis
Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated. If cancer arises from cellular mutation, why don't we all have the disease ...
6 hours ago
0
4
Researchers uncover the driving force behind a lethal infant brain tumor
An international team led by researchers at Baylor College of Medicine, Texas Children's Hospital, McGill University and University of Pittsburgh School of Medicine has discovered what drives the growth of a lethal pediatric ...
6 hours ago
0
3
ZR fusion protein sways normal brain cell development toward cancer growth, study reveals
A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital and collaborating institutions reveal in the journal Nature a novel mechanism that drives the development ...
6 hours ago
0
1
Cellular 'atlas' of prostate cancer opens new avenues for earlier detection
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the Garvan Institute of Medical Research have produced the world's most detailed cellular "atlas" of ...
8 hours ago
0
4
Form of infant leukemia caused by NUTM1 gene rearrangements found to be highly treatable
Despite a host of checks and balances that usually prevent harmful genetic mutations, sometimes mistakes happen, with serious consequences. Now, researchers from Japan elucidate how a common mutation underlying a common childhood ...
7 hours ago
0
1
Breast cancer recurrence remains low, even after 10 years, with radiotherapy tailored to patient's individual risk
The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings of a 10-year study presented ...
23 hours ago
0
11
Breast reconstruction using polyurethane-coated implants found to reduce scarring and the need for further surgery
Women who are treated with a mastectomy for breast cancer often choose to have surgery to reconstruct the breast using an implant. But hard, painful scar tissue can form around the implant, especially when women have radiotherapy ...
23 hours ago
0
7
Previously unrecognized immune response could enhance defense against cancer
In a paradigm-breaking study, researchers have discovered a novel way the immune system, specifically T cells, attack their target cells, reshaping long-held assumptions in immunology and demonstrating direct implications ...
Mar 24, 2026
0
171
A protein may help revive exhausted T cells in cancer immunotherapy
Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis from the broad-spectrum approach of chemotherapy to prompting the immune system's boldest warriors—its ...
Before surgery, a biopsy gene test could reveal which lung tumors are likely to recur
Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon cancer combined. When lung adenocarcinoma, the most common primary lung cancer in the U.S., grows into ...
Mar 24, 2026
0
4
Immune cell 'bloodhounds' track cancer cells' unique metabolic signatures and eliminate tumors in mice
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine researchers. The approach equips ...
Mar 24, 2026
0
14
How inflammation drives bone loss in an aggressive childhood leukemia
A rare form of leukemia known as TCF3::HLF-positive B cell acute lymphoblastic leukemia (B-ALL) sits among the most aggressive blood cancers seen in children. The disease causes a rapid buildup of abnormal blood cells, but ...
Mar 24, 2026
0
2
Open-access predictive tool could improve monitoring of smoldering multiple myeloma
Dana-Farber Cancer Institute investigators have developed an online, easy-to-use tool that more accurately predicts when a precursor blood condition called smoldering multiple myeloma is likely to turn into active cancer ...
Mar 24, 2026
0
2
FDA-approved fatty liver drug also suppresses liver tumors in mice
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the HKU State Key Laboratory of Liver Research, has found ...
Mar 24, 2026
0
5
Chronic stress linked to faster cancer progression in multiple tumor types
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic ...
Mar 24, 2026
0
4
Online intervention helps cancer patients share genetic testing results with family
When a person with cancer finds out they carry an inherited genetic variant that puts them at higher risk of cancer, the results can help inform their treatment or steps to prevent additional cancer.
Mar 24, 2026
0
1
Bone pain reduced with pegfilgrastim administration 72 hours after chemo
For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 hours, according to a study published online ...
Mar 24, 2026
0
1
Agent Orange linked to aggressive bone marrow cancer in Vietnam veterans
More than 50 years after Agent Orange was used in Vietnam, a new national study published in Blood Advances highlights the genetic changes that link exposure to Agent Orange to myelodysplastic syndromes (MDS), a group of ...
Mar 24, 2026
0
3
Genetic weakness may help target deadly small cell neuroendocrine cancers
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine cancers, aggressive ...
Mar 23, 2026
0
37
